AstraZeneca Puts $2 Billion Behind Summit's Ivonescimab, Pairing the PD-1/VEGF Bispecific With Its ADC Portfolio / ADC, Akeso ...

Lindsay Clancy is set to return to court Tuesday for a hearing that could help decide whether she will face a second trial in ...

Chronic pancreatitis is characterised by complex, multifactorial pain affecting 80–90% of patients. Pain arises from overlapping nociceptive and neuropathic mechanisms, often accompanied by CNS ...

The former England rugby star, 47, said it was 'a relief' that his father was now 'free of his body', and said the experience had left him in favour of assisted dying. After last week announcing the ...

The head of Ethiopia’s army suggested that neighboring Eritrea, Sudan and Egypt were supporting rebel troops who have ...

Research that won the 10th Bioindustry AwardOn July 15, 2026, Sumitomo Pharma Co., Ltd. and RACTHERA Inc. announced that the ...

JUVMO™ is the first and only selective D1/D5 receptor agonist approved for adults with Parkinson's disease1 Taken once daily with or without levodopa therapy, JUVMO offers patients ...

Many well known actors have continued working while dealing with serious health challenges, and their medical journeys often ...

Patrick Clancy revealed which ‘miracle’ treatment he did that ‘helped the most’ while processing the trauma after Lindsay ...

The causes of Parkinson's disease (PD) have not yet been fully elucidated, but in addition to aging and genetic factors, ...

Company CEO outlines the differentiated mechanism and clinical potential of Ampligen in pancreatic cancer Survival data ...